Yangyan Cui
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
- Cancer-related gene regulation
Papers in
-
- Cancer, Hypoxia, and Metabolism 2
- NF-κB Signaling Pathways 1
-
- Epigenetics and DNA Methylation 3
- Cell death mechanisms and regulation 1
- Co-authors
- Jun Yan (6 shared papers)Ruimin Huang (7 shared papers)Hongqian Guo (4 shared papers)Xiaojing Huang (3 shared papers)Dianzheng Zhang (3 shared papers)Lan Shen (2 shared papers)Xiaozhi Zhao (2 shared papers)Junlong Zhuang (2 shared papers)
- Journals
- Theranostics (3 papers)Journal of Biological Chemistry (1 paper)Integrative Cancer Therapies (1 paper)Frontiers in Oncology (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Yangyan Cui
9 papers receiving 449 citations
Peers
Comparison fields: 5 of 48
- Cancer Research 182
- Molecular Biology 294
- Pulmonary and Respiratory Medicine 102
- Rehabilitation 20
- Oncology 63
Countries citing papers authored by Yangyan Cui
This map shows the geographic impact of Yangyan Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangyan Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangyan Cui more than expected).
Fields of papers citing papers by Yangyan Cui
This network shows the impact of papers produced by Yangyan Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangyan Cui. The network helps show where Yangyan Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Yangyan Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 134 | |
| 2 | 2015 | 127 | |
| 3 | 2017 | 52 | |
| 4 | 2014 | 50 | |
| 5 | 2015 | 40 | |
| 6 | 2020 | 24 | |
| 7 | 2024 | 14 | |
| 8 | 2013 | 13 | |
| 9 | 2022 | 1 |
About Yangyan Cui
Yangyan Cui is a scholar working on Cancer Research, Molecular Biology, Surgery, Rehabilitation and Biochemistry, having authored 9 papers that have together received 455 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer Mechanisms and Therapy (1 paper), Magnolia and Illicium research (1 paper), Spinal Hematomas and Complications (1 paper), Cell death mechanisms and regulation (1 paper) and NF-κB Signaling Pathways (1 paper). The work is most often cited by research in Cancer Research (182 citations), Molecular Biology (294 citations), Pulmonary and Respiratory Medicine (102 citations), Rehabilitation (20 citations) and Oncology (63 citations). Yangyan Cui has collaborated with scholars based in China and United States. Frequent co-authors include Jun Yan, Ruimin Huang, Hongqian Guo, Xiaojing Huang, Dianzheng Zhang, Lan Shen, Xiaozhi Zhao, Junlong Zhuang, Qun Lu and Lin Yang. Their work appears in journals such as Theranostics, Journal of Biological Chemistry, Integrative Cancer Therapies, Frontiers in Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.